Loading institutional data...
Loading institutional data...
Institutional accumulation: ownership increased +0.91% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $3.11 today, the market must believe free cash flow compounds 11.3%/yr for a decade (off $3M normalized FCF).
2-stage DCF · 0.03B shares · net debt -$12M
mean -350.7% · volatility σ 248% · implied rate exceeded in 0/3 yrs
Central path = implied 11.3%/yr growth; shaded band = ±1σ (248%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.1M 100.0% | $22.6M 100.0% | $25.1M 100.0% | $25.0M 100.0% | $24.4M 100.0% | $28.3M 100.0% | $33.4M 100.0% | $35.9M 100.0% | $33.2M 100.0% | $24.5M 100.0% |
| Cost of Revenue | $17.2M 63.7% | $12.7M 56.4% | $14.9M 59.4% | $13.9M 55.7% | $12.8M 52.5% | $17.4M 61.7% | $20.9M 62.7% | $22.3M 62.1% | $20.2M 61.0% | $15.2M 62.0% |
| Cost of Products | — | — | — | — | — | — | — | $7.8M 21.7% | $8.0M 24.1% | $7.2M 29.4% |
| Cost of Services | — | — | — | — | — | — | — | $10.7M 29.8% | $10.2M 30.7% | $8.0M 32.7% |
| Gross Profit | $9.8M 36.3% | $9.9M 43.6% | $10.2M 40.6% | $11.1M 44.3% | $11.6M 47.5% | $10.8M 38.3% | $12.5M 37.3% | $13.6M 37.9% | $13.0M 39.0% | $9.3M 38.0% |
| Research & Development | $1.2M 4.3% | $962K 4.3% | $840K 3.3% | $733K 2.9% | $542K 2.2% | $767K 2.7% | $1.5M 4.4% | $1.3M 3.6% | $937K 2.8% | $667K 2.7% |
| Selling, General & Admin | $13.5M 49.9% | $11.4M 50.2% | $11.9M 47.3% | $10.9M 43.6% | $9.8M 40.1% | $16.8M 59.4% | $17.1M 51.3% | $19.1M 53.3% | $12.7M 38.3% | $10.3M 42.0% |
| Total Operating Expenses | $18.1M 66.7% | $14.4M 63.7% | $14.6M 58.1% | $13.4M 53.7% | $12.8M 52.5% | $16.8M 59.4% | — | — | — | — |
| Operating Income | -$8.2M -30.5% | -$4.5M -20.0% | -$4.4M -17.6% | -$2.3M -9.4% | -$1.2M -5.0% | -$6.0M -21.1% | -$4.7M -13.9% | -$5.5M -15.4% | $225K 0.7% | -$997K -4.1% |
| Interest Expense | $150K 0.6% | $90K 0.4% | $16K 0.1% | $16K 0.1% | $14K 0.1% | $126K 0.4% | $102K 0.3% | $120K 0.3% | $155K 0.5% | $176K 0.7% |
| Other Income (Expense), net | $16K 0.1% | -$117K -0.5% | -$77K -0.3% | -$32K -0.1% | $5.0M 20.4% | -$227K -0.8% | — | — | — | — |
| Pretax Income | -$8.2M -30.4% | -$4.7M -20.6% | -$4.5M -17.9% | -$2.4M -9.5% | $3.8M 15.4% | -$6.2M -21.9% | -$4.8M -14.3% | -$5.8M -16.1% | $98K 0.3% | -$1.2M -4.7% |
| Income Tax Expense | $21K 0.1% | $23K 0.1% | $32K 0.1% | $16K 0.1% | $19K 0.1% | $30K 0.1% | $15K 0.0% | $33K 0.1% | $0 0.0% | $0 0.0% |
| Net Income | -$8.2M -30.5% | -$4.8M -21.0% | -$4.6M -18.3% | -$2.4M -9.8% | $3.7M 15.1% | -$6.2M -21.8% | -$4.7M -14.1% | -$5.7M -15.9% | $47K 0.1% | -$1.1M -4.5% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.30 | $-0.19 | $-0.19 | $-0.10 | $0.15 | $-0.25 | — | $-0.23 | $0.00 | $-0.06 |
| EPS (Diluted) | $-0.30 | $-0.19 | $-0.19 | $-0.10 | $0.15 | $-0.25 | — | $-0.23 | $0.00 | $-0.06 |
| Weighted Avg Shares (Basic) | 27.2M | 24.9M | 24.9M | 24.9M | 24.9M | 24.9M | — | 24.8M | 23.2M | 19.3M |
| Weighted Avg Shares (Diluted) | 27.2M | 24.9M | 24.9M | 24.9M | 25.1M | 24.9M | — | 24.8M | 23.3M | 19.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
2/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$10M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -38%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 12-yr range · 75th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 12-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 4.2× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 62.1 | 62.7 | 61.7 | 52.5 | 55.7 | 59.4 | 56.4 | 63.7 |
| Gross Profit | 37.9 | 37.3 | 38.3 | 47.5 | 44.3 | 40.6 | 43.6 | 36.3 |
| R&D | 3.6 | 4.4 | 2.7 | 2.2 | 2.9 | 3.3 | 4.3 | 4.3 |
| SG&A | 53.3 | 51.3 | 59.4 | 40.1 | 43.6 | 47.3 | 50.2 | 49.9 |
| Operating Income | -15.4 | -13.9 | -21.1 | -5.0 | -9.4 | -17.6 | -20.0 | -30.5 |
| Income Tax | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Net Income | -15.9 | -14.1 | -21.8 | 15.1 | -9.8 | -18.3 | -21.0 | -30.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on TGEN: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $29.49T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $371.6B | 42.5× | 29.7× | 5.5× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.8B | 38.5× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $259.8B | 39.0× | 18.5× | 2.9× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $199.4B | 79.4× | 40.2× | 2.2× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $185.4B | 37.1× | — | 4.1× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $177.4B | 47.9× | 31.6× | 5.5× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $167.6B | 23.6× | 16.1× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $158.8B | 39.2× | — | 5.8× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.2B | 28.1× | 16.1× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.2B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $118.7B | 34.1× | 26.8× | 6.0× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.3B | 24.9× | — | 4.9× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $96.2B | 23.0× | 16.9× | 1.8× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.4B | 32.6× | 23.3× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $92.4B | 70.8× | 43.8× | 9.0× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| PWR | $92.2B | 90.7× | 45.8× | 3.2× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| JCI | $91.9B | 28.0× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $90.7B | 60.9× | 39.9× | 11.0× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $87.3B | 27.4× | 16.8× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.0B | 31.8× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $85.0B | 15.3× | 9.5× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $83.0B | 36.5× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $79.8B | 45.0× | 28.7× | 7.7× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| TGEN | $93M | — | — | 3.4× | 19.7% | 36.3% | -30.5% | -38.1% | -38.1% | — | 61 |
Peers = companies sharing TGEN's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.